Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
300937 Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical
- 28.60
- +0.42+1.49%
Market Closed Dec 20 15:00 CST
2.74BMarket Cap117.21P/E (TTM)
29.20High28.04Low30.94KlotVolume28.20Open28.18Pre Close88.80MTurnover4.94%Turnover Ratio45.98P/E (Static)95.67MShares37.5352wk High3.23P/B1.79BFloat Cap17.6152wk Low33.82Limit Up62.65MShs Float149.38Historical High22.54Limit Down4.12%Amplitude17.61Historical Low0.22Dividend TTM28.70Avg Price14.95KlotAsk0.77%Div YieldTTM100Lot Size14.59KlotBid
Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.72%3.24B | 0.93%2.23B | 10.29%1.24B | 11.62%4.43B | 19.75%3.21B | 25.40%2.2B | 23.29%1.12B | 16.72%3.97B | 11.49%2.68B | 10.35%1.76B |
| Operating revenue | 0.72%3.24B | 0.93%2.23B | 10.29%1.24B | 11.62%4.43B | 19.75%3.21B | 25.40%2.2B | 23.29%1.12B | 16.72%3.97B | 11.49%2.68B | 10.35%1.76B |
| Other operating revenue | ---- | 48.84%15.08M | ---- | -0.48%23.54M | ---- | 7.48%10.13M | ---- | 45.73%23.65M | ---- | 719.53%9.43M |
| Total operating cost | 2.52%3.21B | 3.23%2.2B | 13.84%1.22B | 11.20%4.34B | 18.18%3.13B | 23.03%2.13B | 19.52%1.07B | 14.98%3.91B | 10.66%2.65B | 9.47%1.73B |
| Operating cost | 1.12%2.96B | 2.27%2.04B | 13.28%1.14B | 11.19%4.06B | 17.40%2.92B | 22.39%1.99B | 19.25%1B | 13.65%3.65B | 9.78%2.49B | 8.62%1.63B |
| Operating tax surcharges | 16.08%5.81M | 6.71%3.79M | -8.22%1.88M | 10.75%7.5M | 10.06%5M | 22.32%3.55M | 36.69%2.05M | 31.84%6.77M | 22.64%4.55M | 10.56%2.91M |
| Operating expense | 26.37%180.91M | 18.61%112.21M | 22.78%53.86M | 17.81%190.62M | 33.05%143.16M | 35.71%94.6M | 26.65%43.87M | 25.38%161.81M | 12.14%107.59M | 14.54%69.71M |
| Administration expense | 14.72%48.26M | 12.19%32.24M | 28.81%16.04M | -3.63%57.47M | 38.72%42.07M | 45.56%28.74M | 37.81%12.45M | 68.21%59.63M | 18.55%30.33M | 2.28%19.74M |
| Financial expense | 84.33%6.58M | 95.41%4.1M | 86.50%2.08M | -4.25%6.99M | -11.01%3.57M | -27.63%2.1M | -30.59%1.12M | 231.37%7.3M | 437.87%4.01M | 488.34%2.9M |
| -Interest expense (Financial expense) | 67.63%7.39M | 121.85%5.08M | 85.59%2.5M | 2.46%6.58M | 11.37%4.41M | -19.63%2.29M | 8.43%1.35M | 253.57%6.42M | --3.96M | 551.61%2.85M |
| -Interest Income (Financial expense) | -18.01%-3.18M | -57.57%-2.49M | 19.66%-1.08M | 4.60%-2.27M | -62.23%-2.7M | -62.53%-1.58M | -390.75%-1.35M | -11.26%-2.38M | ---1.66M | 20.40%-970.97K |
| Research and development | -11.02%12.57M | 1.09%9.32M | 2.69%4.8M | 9.11%19.32M | 7.83%14.12M | 6.50%9.22M | -6.12%4.67M | 55.63%17.71M | --13.1M | --8.66M |
| Credit Impairment Loss | 26.77%-15.38M | 12.71%-16.14M | 4.65%-17.06M | -13.33%-13.16M | -3.68%-21M | -7.61%-18.49M | -201.68%-17.89M | -431.23%-11.61M | -83.24%-20.26M | -57.50%-17.18M |
| Asset Impairment Loss | 129.21%816.31K | 157.10%684.53K | 125.91%636.78K | -8.03%-9.09M | 13.30%-2.79M | 81.60%-1.2M | 35.53%-2.46M | -96.15%-8.42M | -5.88%-3.22M | -112.18%-6.52M |
| Other net revenue | 30.16%-14.14M | 6.20%-15.33M | 21.63%-15.71M | -13.76%-17.09M | -13.61%-20.25M | 19.63%-16.34M | -176.39%-20.04M | -323.66%-15.03M | -520.61%-17.82M | -578.77%-20.34M |
| Invest income | -215.91%-468.07K | -196.52%-394.33K | -164.72%-20.45K | 135.89%1.54M | 126.31%403.82K | 156.83%408.56K | 122.36%31.6K | -157.08%-4.29M | -114.59%-1.54M | -106.83%-718.95K |
| -Including: Investment income associates | -183.32%-2.02M | -1,011.07%-1.5M | ---556.09K | 28.27%-862.51K | 44.36%-713.58K | 143.13%164.16K | ---- | -1,049.52%-1.2M | ---1.28M | -105.27%-380.64K |
| Asset deal income | -35,167.54%-496.97K | -17,074.29%-598.65K | ---31.61K | 33.45%-52.69K | 131.65%1.42K | 476.49%3.53K | ---- | 27.09%-79.18K | -98.38%611.77 | -74.26%611.77 |
| Other revenue | -55.81%1.39M | -61.85%1.12M | 183.56%761.65K | -60.82%3.67M | -56.25%3.15M | -28.16%2.93M | -89.78%268.61K | 61.98%9.37M | -7.48%7.2M | -46.95%4.08M |
| Operating profit | -82.96%10.23M | -84.73%8.52M | -81.26%6.45M | 45.41%68.6M | 314.23%60.05M | 1,150.64%55.83M | 259.17%34.41M | 409.33%47.17M | -6.61%14.5M | -68.43%4.46M |
| Add:Non operating Income | -37.00%917.4K | -42.46%801.53K | 42.78%65.89K | 883.78%1.66M | 492.79%1.46M | 1,677.28%1.39M | -51.81%46.15K | 800.12%168.26K | 7,716.01%245.64K | 5,328.70%78.38K |
| Less:Non operating expense | 310.84%770.92K | 113.92%494.3K | 69.48%110.27K | -84.85%371.45K | -36.87%187.65K | 543.05%231.07K | 242.93%65.06K | 112.09%2.45M | -48.62%297.25K | -85.57%35.93K |
| Total profit | -83.07%10.38M | -84.50%8.83M | -81.38%6.4M | 55.67%69.88M | 324.49%61.31M | 1,164.65%56.99M | 256.12%34.39M | 452.54%44.89M | -3.37%14.44M | -67.56%4.51M |
| Less:Income tax cost | -100.79%-92.08K | -111.22%-1.16M | -116.22%-791.18K | 49.73%13.11M | 132.45%11.67M | 244.56%10.34M | 117.67%4.88M | 527.42%8.75M | 109.58%5.02M | 68.27%3M |
| Net profit | -78.90%10.47M | -78.58%9.99M | -75.62%7.19M | 57.11%56.77M | 426.78%49.65M | 2,996.33%46.65M | 297.98%29.51M | 437.01%36.14M | -24.92%9.42M | -87.56%1.51M |
| Net profit from continuing operation | -79.85%10.47M | -78.58%9.99M | -75.62%7.19M | 57.11%56.77M | 451.62%51.99M | 2,996.33%46.65M | 297.98%29.51M | 437.01%36.14M | --9.42M | -87.56%1.51M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---2.34M | ---- | ---- | ---- | ---- | ---- |
| Less:Minority Profit | -576.04%-3.46M | -3,203.80%-2.1M | 4.39%-2.03M | 53.09%-2.76M | 93.04%-511.55K | 98.90%-63.7K | -23.36%-2.12M | -1,887.28%-5.88M | -568.66%-7.35M | -280.88%-5.78M |
| Net profit of parent company owners | -72.22%13.93M | -74.11%12.1M | -70.84%9.23M | 41.69%59.53M | 198.95%50.16M | 540.72%46.72M | 246.22%31.63M | 556.48%42.02M | 52.77%16.78M | -18.18%7.29M |
| Earning per share | ||||||||||
| Basic earning per share | -71.15%0.15 | -73.47%0.13 | -70.79%0.0964 | 40.91%0.62 | 188.89%0.52 | 512.50%0.49 | 230.00%0.33 | 528.57%0.44 | 50.00%0.18 | -20.00%0.08 |
| Diluted earning per share | -71.15%0.15 | -73.47%0.13 | -70.79%0.0964 | 40.91%0.62 | 188.89%0.52 | 512.50%0.49 | 230.00%0.33 | 528.57%0.44 | 50.00%0.18 | -20.00%0.08 |
| Other composite income | 200.00%1.5M | 1.5M | 1.5M | -1.5M | ||||||
| Other composite income of parent company owners | ---- | ---- | ---- | 200.00%1.5M | --1.5M | --1.5M | ---- | ---1.5M | ---- | ---- |
| Other composite income of minority owners | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Total composite income | -79.52%10.47M | -79.25%9.99M | -75.62%7.19M | 68.22%58.27M | 442.66%51.14M | 3,095.68%48.15M | 297.98%29.51M | 414.77%34.64M | -24.92%9.42M | -87.56%1.51M |
| Total composite income of parent company owners | -73.03%13.93M | -74.91%12.1M | -70.84%9.23M | 50.62%61.03M | 207.87%51.65M | 561.25%48.21M | 246.22%31.63M | 533.09%40.52M | 52.77%16.78M | -18.18%7.29M |
| Total composite income of minority owners | -576.04%-3.46M | -3,203.80%-2.1M | 4.39%-2.03M | 53.09%-2.76M | 93.04%-511.55K | 98.90%-63.7K | -23.36%-2.12M | -1,887.28%-5.88M | -568.66%-7.35M | -280.88%-5.78M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
